In Russia, over the past day, 19,573 people were hospitalized with a diagnosis of coronavirus infection - 10.3% less than the day before (21,833).

The daily increase in the number of patients with COVID-19 nationwide was 179,284 (166,631 was recorded on February 14).

Most new cases were detected in Moscow (11,262).

Over the past day, 172,468 patients have fully recovered, 748 people have died.

The total number of coronavirus cases registered in Russia has reached 14,659,880.

Antibodies to the coronavirus strain Omicron do not neutralize previous variants of SARS-CoV-2 well, said virologist Anatoly Altshtein, Doctor of Medical Sciences.

“Now there is evidence that neutralizing antibodies that are produced in response to Omicron neutralize previous strains rather poorly.

We still have Delta, the rest play almost no role in the development of this epidemic, ”he said in an interview with Sputnik radio.

According to him, those who have been ill with Omicron should be vaccinated in order to get full protection against other mutations of the coronavirus infection.

“We need to get vaccinated in a couple of months.

Still, you need to fully recover from the infection, get the immunity that Omicron gives, and then you can be vaccinated.

The vaccine will strengthen immunity not only against Omicron, but also against other viruses.

This is how we will fight the “tail” of the pandemic, when the main epidemic subsides, vaccination will help here,” he added.

The situation with coronavirus infection in Russia will be calm in the coming months, as a significant part of the population has been ill with the omicron strain, Andrey Isaev, founder and general director of the DNCOM Research Center for Molecular Genetic Research, believes.

“Judging by the fact that the majority of the population has been ill with Omicron, the situation with coronavirus is likely to be quite calm, at least until the May holidays.

But it is important to understand: we cannot predict what the mutagenesis of the virus will bring us, whether it will give us new strains, ”TASS quoted him as saying.

  • AGN "Moscow"

  • © Zykov Kirill

We can talk about a downward trend in the incidence of coronavirus in the Moscow region, added Vladislav Zhemchugov, Doctor of Medical Sciences, an immunologist, a specialist in especially dangerous infections.

“It (the epidemic situation. - RT ) will inevitably improve - the number of infected people will come to naught, because there are a finite number of people, this cannot continue indefinitely.

Everyone will get acquainted with the virus in one form or another, including in the form of a vaccine... It must be borne in mind that people can get sick again, including those who have been vaccinated, so... there will be some slippage in time... I think that's why now there is a plateau, ”RIA Novosti quotes him.

According to the capital’s operational headquarters, 1,036 people with COVID-19 have been hospitalized in Moscow over the past day.

During this period, 11,262 new cases were identified, 37,779 patients recovered, 87 people died.

All were diagnosed with pneumonia and tested positive for COVID-19.

National Research Center for Epidemiology and Microbiology named after N.F.

Gamaleya will soon receive permission to conduct clinical trials of a drug for coronavirus infection based on monoclonal antibodies.

This was stated by the director of the center Alexander Gintsburg.

“A package of documents for obtaining permission for clinical trials has been submitted.

As far as I know, permission should be obtained in the near future, ”he explained.

In December 2020, the Gamaleya National Research Center for Epidemiology and Microbiology reported that they were developing a drug for the treatment of COVID-19 based on monoclonal antibodies.

The 45th President of the United States Donald Trump was treated with a similar analogue.

On January 16, it became known that studies of this drug had begun at the Gamaleya Center.

They will last approximately three to four months.

In addition, Gunzburg spoke about the progress of trials of the Sputnik V nasal vaccine, which began in the second half of January: “Fifty-three people were vaccinated yesterday morning.

Volunteers have no complications.”

According to him, the drug is not dangerous for the body, since it does not contain a live virus.

On the eve of the deputy mayor of Moscow, Anastasia Rakova also announced that clinical trials of the Generium nasal vaccine had begun on the basis of six city polyclinics.

On January 31, free voluntary vaccination of adolescents aged 12 to 17 against coronavirus by Sputnik M began in Moscow.